YKP3089
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for YKP3089, covering 2014-01-31 to 2022-04-29. Get the full timeline:
Most recent: Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures [Phase 2]